Pages that link to "Q24298218"
Jump to navigation
Jump to search
The following pages link to Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene (Q24298218):
Displaying 50 items.
- tumor protein p53 (Q283350) (← links)
- Wild-type p53 binds to the TATA-binding protein and represses transcription (Q24300991) (← links)
- Interaction of p53 with the human Rad51 protein (Q24309466) (← links)
- Identification of a novel p53 functional domain that is necessary for efficient growth suppression (Q24311276) (← links)
- Stimulation of p53-mediated transcriptional activation by the p53-binding proteins, 53BP1 and 53BP2 (Q24316208) (← links)
- MSG1 and its related protein MRG1 share a transcription activating domain (Q24321610) (← links)
- PML, a growth suppressor disrupted in acute promyelocytic leukemia (Q24324168) (← links)
- Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway (Q24324455) (← links)
- Repression of p53-mediated transcription by MDM2: a dual mechanism (Q24336020) (← links)
- Two domains of p53 interact with the TATA-binding protein, and the adenovirus 13S E1A protein disrupts the association, relieving p53-mediated transcriptional repression (Q24336035) (← links)
- p53: 25 years after its discovery (Q24338379) (← links)
- p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage (Q24530584) (← links)
- Human TAFII31 protein is a transcriptional coactivator of the p53 protein (Q24562978) (← links)
- Dephosphorylation of simian virus 40 large-T antigen and p53 protein by protein phosphatase 2A: inhibition by small-t antigen (Q24603984) (← links)
- The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes (Q24608783) (← links)
- Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53 (Q24609153) (← links)
- The first 30 years of p53: growing ever more complex (Q24645732) (← links)
- Cytoplasmic p53 polypeptide is associated with ribosomes (Q24646226) (← links)
- Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene (Q24655012) (← links)
- Novel Implications of DNA Damage Response in Drug Resistance of Malignant Cancers Obtained from the Functional Interaction between p53 Family and RUNX2 (Q26777988) (← links)
- The p53 pathway as a target in cancer therapeutics: obstacles and promise (Q27690770) (← links)
- Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms (Q27730393) (← links)
- MDM2--master regulator of the p53 tumor suppressor protein (Q28138926) (← links)
- Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription (Q28187745) (← links)
- Physical interaction and functional antagonism between the RNA polymerase II elongation factor ELL and p53 (Q28198423) (← links)
- Definition of a consensus binding site for p53 (Q28207794) (← links)
- The p53 circuit board (Q28259725) (← links)
- Identification of p53 as a sequence-specific DNA-binding protein (Q28282745) (← links)
- Mouse p53 represses the rat brain creatine kinase gene but activates the rat muscle creatine kinase gene (Q28565834) (← links)
- c-Krox binds to several sites in the promoter of both mouse type I collagen genes. Structure/function study and developmental expression analysis (Q28593051) (← links)
- P53, cell cycle control and apoptosis: Implications for cancer (Q28611435) (← links)
- p53 oligomerization and DNA looping are linked with transcriptional activation (Q28639938) (← links)
- Interaction of p53 with its consensus DNA-binding site (Q28639970) (← links)
- Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product (Q28645822) (← links)
- Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours (Q29547697) (← links)
- Cancer. p53, guardian of the genome (Q29615610) (← links)
- Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53 (Q29615851) (← links)
- Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53 (Q29617850) (← links)
- mdm2 expression is induced by wild type p53 activity (Q29618316) (← links)
- p53 is required for radiation-induced apoptosis in mouse thymocytes (Q29620281) (← links)
- Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53. (Q30450287) (← links)
- Molecular genetics of neurological tumours (Q30495393) (← links)
- Molecular mechanisms of cancer (Q30498610) (← links)
- cDNA cloning and expression analysis of flounder p53 tumour suppressor gene (Q31909829) (← links)
- Mechanisms of p53-induced apoptosis: in search of genes which are regulated during p53-mediated cell death (Q33534053) (← links)
- Prognostic and predictive value of p53 and p21 in breast cancer (Q33538430) (← links)
- Signal transduction and transcription factors in rheumatic disease (Q33598827) (← links)
- Molecular understanding of lung cancers-A review (Q33628898) (← links)
- p53 and the CNS: tumors and developmental abnormalities (Q33632282) (← links)
- Insights into cancer from transgenic mouse models (Q33643327) (← links)